The FDA says it will use artificial intelligence to expedite the approval of new drugs and devices. Investigators with the legal services watchdog group, Drugwatch.com point out some of the problems ...

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

The information provided by the AI-powered platform is expected to help individuals better understand how their lifestyle and behavior affect their glucose levels. The app translates these glucose ...

Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

Precigen, Inc. (NASDAQ:PGEN) is one of the best multibagger penny stocks to buy according to analysts. On August 15, the ...

The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be ...

On June 2, the FDA dropped the other shoe, saying it had launched a generative AI tool called “Elsa” to help scientific reviewers and investigators work more efficiently.